Background and Purpose: The Chedoke-McMaster Stroke Assessment measures the physical impairments and disabilities that impact on the lives of individuals with stroke. This measure has three overall purposes: 1) to stage motor recovery to classify individuals in terms of clinical characteristics, 2) to predict rehabilitation outcomes, and 3) to measure clinically important change in physical function. This study was carried out to evaluate the ability of this measure to yield reliable and valid results.
In stroke rehabilitation, as elsewhere in health care, properly constructed, valid, and reliable measures are needed to discriminate among subjects, to predict future states, and to evaluate patient outcomes or the effectiveness of interventions.' In the call for action of the National Symposium on Methodological Issues in Stroke Outcome Research, Basmajian2 reinforced the need to discriminate among individuals with stroke. He pointed out that "rehabilitation professions must develop working models of diagnostic classification in order to evaluate and improve prognosis and treatment." Stroke survivors do not make up a homogeneous group in terms of clinical characteristics and natural history.23 Earlier, Feinstein et a14 had noted that reliable and valid assessments that incorporate classifica-tion of individuals into homogeneous subgroups foster logical prediction, treatment, and evaluation decisions.
The International Classification of Impairment, Disability, and Handicap provides a generally accepted framework for outcome evaluation. According to Smith,5 the targets of effective therapy are generally disability and handicap. It is these attributes as a direct reflection of a patient's functional level, not impairment, that should be measured to determine rehabilitation outcomes.
The Chedoke-McMaster Stroke Assessment (Chedoke Assessment) is a two-part measure made up of both a physical impairment inventory and a disability inventory. This new measure has two advantages. The impairment inventory can classify patients into homogeneous subgroups based on the stage of motor recovery, and the disability inventory measures change in disability (or inversely, physical function), not just impairment.
The purpose of the Chedoke Assessment's impairment inventory is to determine the presence and severity of common physical impairments to classify or stratify patients when planning and selecting interventions and evaluating their effectiveness. It has six dimensions, each measured on a 7-point scale. These dimensions include shoulder pain, postural control, the arm, the hand, the leg, and the foot. The purpose of the Chedoke Assessment's disability inventory (Appendix 2) is to measure clinically important change in physical disability (apart from the arm). This inventory is designed to be used in conjunction with the Uniform Data System for Medical Rehabilitation (UDS), which includes the Functional Independence Measure (FIM). 18 The disability inventory consists of a gross motor function index and a walking index. The measurement of these attributes is considered important for the evaluation of outcome and for the determination of effectiveness of therapeutic interventions. The inventory has a maximum total score of 100 (70 from the gross motor function index, which has 10 items, and 30 from the walking index, with five items). With the exception of item 15, each item is scored on the same 7-point scale as the FIM. To score item 15, the 2-minute walking test19 is used to assess the gait efficiency of ambulating patients. If Tables 1 and 2 . Based on International Classification of Diseases-9 Codes, three subjects had a principal diagnosis of intracerebral hemorrhage, two of basilar artery occlusion, three of occlusion or stenosis of precerebral arteries, four of occlusion of cerebral arteries, two of acute but ill-defined cerebrovascular disease, four of late effects of cerebrovascular disease, 13 of spastic hemiplegia, and one of quadriplegia with brain stem infarction. Concurrent neurological deficits included hemianopsia in seven subjects, sensory involvement in 23, and seizure disorders in five. The majority of subjects were vigilant, with three classified as lethargic and three others as attentive. Many subjects had some degree of cardiac pathology; this included such disorders as congestive heart failure, atrial fibrillation, myocardial infarction, angina, or cardiomyopathy. Comorbidity was common; three subjects had diabetes, three had congestive obstructive pulmonary disease, and two had osteoarthritis of the knees. During the rehabilitation stay five subjects were diagnosed with a urinary tract infection. Discharge data were available from 29 subjects; during the course of the study two subjects died and one withdrew due to illness. The Chedoke Assessment's three purposes dictated the evaluation study's objectives and design. The five objectives used to determine the reliability and validity of the measure and the design for each are as follows. Values are number of patients.
Objective 1 This was to evaluate the interrater and intrarater reliabilities of the impairment inventory. To meet this objective, patients were assessed concurrently by both a treating and a research physical therapist during the first week of admission. Random assignment was used to determine who would handle the patient during the assessment. The assessment was videotaped, and the treating therapist scored the videotape after a minimum interval of 2 weeks.
Three research physical therapists and three treating physical therapists gathered the study data. The research therapists had no prior knowledge of the patients in the study and little familiarity with the Chedoke Assessment. Before the study subjects were tested, the therapists read and discussed the administration guidelines. Areas of possible disagreement in interpretation of patient performance were identified, discussed, and resolved. Each therapist then tested one patient, following which further discrepancies were explored. The experience of the treating therapists with the Chedoke Assessment ranged from 4 months to 5 years.
For Objectives 1 and 2, the point estimates of acceptable reliability were set a priori at a Type 2,1 intraclass correlation coefficient (ICC)21 of at least 0.90 for the total score of the two inventories and at least 0.80 for each of the six impairment dimensions and two disability indexes. We also stipulated that the lower 95% confidence level of the ICC should be greater than 0.80 for the inventory total scores for the measure to be clinically useful.
Objective 2
This was to determine the interrater and test-retest reliabilities of the disability inventory. Because this inventory is designed to discriminate among patients at a given point in time and to assess change in a patient's function, it was important to assess the amount of variability that a patient would show in a "stable" state. Patients were assessed concurrently by both the treating and research therapists on admission and again within 5 days. Random assignment was used to determine who would handle the patient during the assessment. Handling was alternated on subsequent assessments of the same patient.
Objective 3
This was to determine the Chedoke Assessment's construct validity. To do this we hypothesized that specific impairments and disabilities would have the highest correlations with similar attributes on other measures and that these correlations would be significantly greater than 0.60. For example, impairment scores were compared with similar impairment subscores on the Fugl-Meyer Test of physical performance8 (i.e., postural control with balance; the sum of arm and hand with the sum of shoulder, elbow, forearm, wrist, and hand; the sum of leg and foot with the sum of hip, knee, foot, and ankle; and shoulder pain with upper limb joint pain), and disability scores were compared with similar disability subscores on the FIM (i.e., the gross motor function index with the mobility subscore, Using an earlier version of the Chedoke Assessment, the predictive properties of the measure in the rehabilitation setting were investigated. We established that the stage of recovery of various impairments provides valid and significant prognostic indicators for outcomes.25 The outcomes considered were activities of daily living; recovery of the arm, leg, and postural control; and gross motor function, gait, and shoulder pain. Using this classification scheme, predictive equations were developed to guide therapists in setting goals when the estimation of discharge potential is an important consideration.25 For example, on admission of a patient to rehabilitation, an equation that considers the stage of recovery of the arm and leg and the weeks after stroke can predict the stage of recovery of the arm at discharge; 81% of the variance in outcome can be explained by this equation. However, predictive validity of the current version has not been examined, nor has the current version been studied to determine its ability to predict functional outcome earlier than 3 weeks after As indicated earlier, the Chedoke Assessment is designed to be used in conjunction with the UDS and the FIM. We chose the same scoring key as the FIM for the disability inventory to provide a consistent model for conceptualizing the degree of independence of the patient, or inversely, the degree of burden on the caregiver. The disability inventory, as demonstrated by the validation of the relative responsiveness of the Chedoke Assessment and the FIM, is meant to be more responsive to change in the physical domain, which is assessed only summarily in the FIM. The disability inventory provides additional information needed to plan a therapeutic intervention that stresses functional activity. Because change in disability is the principal outcome of interest, we designed the disability inventory specifically to pick up small but important change in patient function.
Although the Chedoke Assessment has been used for many years in the clinical setting, the understanding of its properties was far from complete. This study addresses some of the obvious concerns about the measure's reliability and validity.
In conclusion, the study reported here further evaluates a measure of physical impairment and disability that can normal. Spasticity as demonstrated by resistance to passive movement is no longer present. A great variety of environmentally specific patterns of movement are now possible. Abnormal patterns of movement with faulty timing emerge when rapid or complex actions are requested. Stage 7. Normal. A "normal" variety of rapid, age-appropriate complex movement patterns are possible with normal timing, coordination, strength, and endurance. There is no evidence of functional impairment compared with the normal side. There is a "normal" sensory-perceptual-motor system.
